menu search

Coherus biosciences' q4 sales fall 34% on lower udenyca volume, prices

Coherus BioSciences Inc's (NASDAQ: Chrs) Q4 net revenue was $73.4 million for Q4 FY21 compared to $1...

February 18, 2022, 5:51 am

Coherus biosciences, inc. (chrs) ceo denny lanfear on q4 2021 results - earnings call transcript

Coherus BioSciences, Inc. (Chrs) CEO Denny Lanfear on Q4 2021 Results - Earnings Call Transcript...

February 17, 2022, 11:10 pm

Coherus biosciences, inc. (chrs) ceo denny lanfear on q4 2021 results - earnings call transcript

Coherus BioSciences, Inc. (Chrs) CEO Denny Lanfear on Q4 2021 Results - Earnings Call Transcript...

February 17, 2022, 11:10 pm

Coherus biosciences, inc. (chrs) ceo denny lanfear on q4 2021 results - earnings call transcript

Coherus BioSciences, Inc. (Chrs) CEO Denny Lanfear on Q4 2021 Results - Earnings Call Transcript...

February 17, 2022, 11:10 pm


Search within

Pages Search Results: